pillbase.ru

Raloxifene hydrochloride

Active substance: raloxifene

TABLET, FILM COATED · RALOXIFENE HYDROCHLORIDE 60 mg/1

United StatesActive

Marketing holder: ScieGen Pharmaceuticals Inc

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 3
  • Evista
    raloxifene hydrochloride
    EMEA/H/C/000184
    Substipharm
  • Optruma
    raloxifene hydrochloride
    EMEA/H/C/000185
    Eli Lilly Nederland B.V.
  • Raloxifene Teva
    raloxifene hydrochloride
    EMEA/H/C/001075
    Teva B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2737-7e95-9c31-45c2b75ab1f1,01a1208c-4aad-7704-882f-655eb5dedacf,01a1208c-682f-736f-b9fe-b1ee0bf60ee0,01a1208c-f23c-77c5-afb4-75c84465e31f,01a1208d-7025-7160-9739-b5e5d32d4e26;count=23 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50228-306
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 50228-306 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50228-306 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50228-306 · Verified 2026-10-09 · open in source